All News

Baclofen use, particularly at higher doses, may result in an increased risk of encephalopathy among patients with chronic kidney disease.

Officials with the FDA have granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi-Sankyo) for the treatment of adults with unresectable or metastatic HER2-positive breast cancer that have received 2 or more prior anti-HER2-based regimens in the metastatic setting.

Tazarotene is the first acne treatment to be available in a lotion form, showing strong efficacy with favorable tolerability.

A study found that intravenous immune globulin dosing optimization through alternative dosing weights represents a significant source of waste reduction and cost reduction.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times

Take care of yourself by providing your body with nutrients that support overall health, your immune system, mood and energy metabolism.

A study found that the total prescriptions for gabapentinoid medications grew from 1.2 million to 3.5 million between 2005-2015.

Will Soliman, PhD, Chairman and CEO of Accreditation Council for Medical Affairs (ACMA) discusses the exciting opportunities available to pharmacists in the pharma industry, in an interview with The Nontraditional Pharmacist.

Enfortumab vedotin-ejfv is the first FDA-approved treatment in the United States for this patient population.